Proactive Investors - Run By Investors For Investors

Elixinol Global attracts $40 million to accelerate international growth initiatives

The company is increasing the capacity of its hemp-derived cannabidiol production facility in the US.
hemp oil
Elixinol is awaiting a medicinal cannabis license in Australia

Elixinol Global Ltd (ASX:EXL) (OTCMKTS:ELLXF) has successfully completed a share placement to domestic and international institutional and sophisticated investors raising $40 million at $1.85 per share.

The group’s portfolio comprises three main divisions: Elixinol USA focused on dietary supplements; Hemp Foods Australia selling food products; and Elixinol Australia, the new start-up focused on medicinal cannabis.

The company listed on the ASX in January this year and raised about $20 million from an oversubscribed initial public offer.

Elixinol chief executive officer Paul Benhaim said: “The global cannabis market is growing at a rapid rate and Elixinol Global recognises the need to move quickly to leverage the opportunity around the business.

“This funding ensures we can seize the market opportunities in front of us, and in doing so, propel the business toward its next phase of growth.”

 

Elixinol will apply the funds towards increasing the capacity of its hemp-derived CBD (cannabidiol) production facility in the US to prepare for increasing levels of demand.

The company will also ramp up its sales force and marketing efforts in the US and Europe.

The new funding will also provide Elixinol with additional working capital to support its growth, pursue strategic investment opportunities and construct its Australian medicinal cannabis facility, upon receipt of a medicinal cannabis license from the Office of Drug Control.

Benhaim added: “We are grateful for the support from existing and new investors who participated in this capital raising in recognition of our world-class brand that continues to drive revenue growth and profitability for Elixinol Global.”

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full EXL profile View Profile

Elixinol Global Ltd Timeline

Related Articles

1542134062_Harvesting-hemp.jpg
November 14 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific
cannabis flower
Tue
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
medicinal cannabis concept
January 31 2019
Zelda has released its December quarterly report confirming multiple trials are on track.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use